Publikasi Scopus 2010 s/d 2022

Muharam R., Prasetyo Y.D., Prabowo K.A., Putri Y.I., Maidarti M., Hestiantoro A.
57191492732;57685883000;57224859187;57687701600;56320510400;8743255100;
IVF outcome with a high level of AMH: a focus on PCOS versus non-PCOS
2022
BMC Women's Health
22
1
172
1
Division of Reproductive Immunoendocrinology, Department of Obstetrics & Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia
Muharam, R., Division of Reproductive Immunoendocrinology, Department of Obstetrics & Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia; Prasetyo, Y.D., Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia; Prabowo, K.A., Division of Reproductive Immunoendocrinology, Department of Obstetrics & Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia; Putri, Y.I., Division of Reproductive Immunoendocrinology, Department of Obstetrics & Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia; Maidarti, M., Division of Reproductive Immunoendocrinology, Department of Obstetrics & Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia; Hestiantoro, A., Division of Reproductive Immunoendocrinology, Department of Obstetrics & Gynecology, Faculty of Medicine, University of Indonesia–Cipto Mangunkusumo National Hospital, Jl. Pangeran Diponegoro No.71, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, 10430, Indonesia
Background: The purpose of this research was to investigate whether high AMH levels in PCOS patients resulted in different IVF outcomes compared to those in non-PCOS patients. Methods: A retrospective cohort study was conducted involving 238 women undergoing IVF who had AMH levels > 4 ng/ml. Participants were divided into two groups: PCOS and non-PCOS. Results: The median AMH level was significantly higher in the PCOS group (7.59 ± 4.61 ng/ml vs. 5.91 ± 2.22 ng/ml, p < 0.001). The PCOS group required less gonadotropin but yielded more oocytes after stimulation. Significantly more participants from the PCOS group (41.5% [n = 39]) developed a hyperresponse to ovarian stimulation compared to the non-PCOS group (26.4% [n = 38]) (OR = 1.978, 95% CI 1.138–3.488; p = 0.015). Conclusion: There were significant differences in terms of total doses of gonadotropin and the number of oocytes retrieved in the PCOS and non-PCOS groups. Women with PCOS and high AMH levels have a higher risk of hyperresponse after ovarian stimulation than women without PCOS. © 2022, The Author(s).
cetrorelix; choriogonadotropin alfa (drug); gonadotropin; Muellerian inhibiting factor; progesterone; recombinant follitropin; Muellerian inhibiting factor; adult; Article; cohort analysis; controlled ovarian stimulation; controlled study; disease severity; female; female infertility; hormone blood level; human; in vitro fertilization; infertility therapy; major clinical study; oocyte number; ovary hyperstimulation; ovary polycystic disease; predictive value; receiver operating characteristic; retrospective study; sensitivity and specificity; treatment outcome; complication; in vitro fertilization; procedures; Anti-Mullerian Hormone; Female; Fertilization in Vitro; Gonadotropins; Humans; Polycystic Ovary Syndrome; Retrospective Studies
BioMed Central Ltd
14726874
35568864
Article
Q2
742
6335